• FirefoxUpgrade to the new Firefox »
  •  Dow Up 2.43% Nasdaq Up 2.24%

    Prothena Corporation plc (PRTA)

    -NasdaqGS
    20.38 0.42(2.10%) Dec 18, 4:00PM EST
    Add to Portfolio
    Prev Close:19.96
    Open:20.38
    Bid:17.13 x 100
    Ask:33.87 x 100
    1y Target Est:41.00
    Beta:-1.498
    Next Earnings Date:N/A
    Day's Range:19.91 - 20.77
    52wk Range:16.71 - 49.24
    Volume:199,560
    Avg Vol (3m):244,797
    Market Cap:558.09M
    P/E (ttm):N/A
    EPS (ttm):-0.22
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for PRTA

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):11.15
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.48
    Quarterly EPS Est (Dec-14) :-0.65
    Mean Recommendation*:1.7
    PEG Ratio (5 yr expected):3.33

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Prothena Corporation plc, a clinical stage biotechnology company, focuses on the discovery, development, and commercialization of novel antibodies for the treatment of various diseases associated with protein misfolding or cell adhesion. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback